Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Category
Global or ExUS Equities - Industry Sector
Sponsor
Franklin Templeton
Fund Family
Index
-
Index Weighting
Active/Passive
Expense
0.50%
Inverse/Leveraged
IPO
Feb 27, 2020
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
Tags
-
Tags
-
Tags
-
Sector/Theme
Region
SMA20
0.82%
SMA50
2.15%
SMA200
16.06%
Return% 1Y
29.20%
Return% 3Y
15.69%
Return% 5Y
-2.65%
Return% 10Y
Return% SI
Flows% 1M
6.38%
Flows% 3M
6.38%
Flows% YTD
30.49%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
71
AUM
34.12M
NAV/sh
52W High
45.58 -4.69%
52W Low
31.24 39.05%
Volatility
1.20% 1.13%
ATR (14)
0.79
RSI (14)
54.72
Beta
0.98
Rel Volume
0.08
Avg Volume
5.92K
Volume
338
Perf Week
3.57%
Perf Month
-0.88%
Perf Quarter
11.46%
Perf Half Y
26.34%
Perf YTD
19.65%
Perf Year
28.73%
Perf 3Y
64.54%
Perf 5Y
-16.61%
Perf 10Y
-
Prev Close
42.65
Price
43.44
Change %
1.86%
Franklin Genomic Advancements ETF seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.